Strategies - Volume 17 > No. 3 - Trademarks & Licensing


ABI PRISM® is a registered trademark of Applied Biosystems, Foster City, CA.

ArrayAssist™, PathwayAssist, and GeneSolve are registered trademarks of Iobion Informatics

Gene Chip® and NetAffx are registered trademarks of Affymetrix

PathwayAssist is a trademark of Ariadne Genomics

Smart Cycler® is a registered trademark of Cepheid, Sunnyvale, CA

SuperScript and Platinum are registered trademarks of Invitrogen Corp.

SYBR® is a registered trademark of Molecular Probes

TaqMan® is a registered trademark of Roche Molecular Systems, Inc.

1. Purchase of this product is accompanied by a limited use license to use the product as a reagent for research purposes. If Purchaser intends to use the product outside the scope of the license, he needs to enter into a License Agreement with F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland or Hoffmann-La Roche Inc.

2. U.S. Patent No. 4,952,496. For academic or non-profit laboratories, an assurance letter accompanies the sale of the products. For commercial laboratories, a research use license agreement must be entered into prior to purchase of the products.

3. Purchase of these products is accompanied by a license to use them in the Polymerase Chain Reaction (PCR) process in conjunction with a thermal cycler whose use in the automated performance of the PCR process is covered by the up-front license fee, either by payment to Applied Biosystems or as purchased, i.e., an authorized thermal cycler.

4. Certain novel fluorescent products, and other products containing hrGFP or cOFP variants, require a license from Stratagene. For license information, please contact Business Development, 858-535-5400 (phone) or 858-535-0071 (fax).

5. Use of the CMV promoter is covered under U.S. Patent Nos. 5,168,062 and 5,385,839 owned by the University of Iowa Research Foundation and licensed FOR RESEARCH USE ONLY.

6. Epitope-tag vector:ll ll Manufactured under license from Sigma-Aldrich Co. under U.S. Patent Nos. 4,703,004, 4,782,137 and 4,851, 341. Other patents pending.

Anti-FLAG antibody: Purchased from Sigma for resale under license from Sigma- Aldrich Co. under U.S. Patent Nos. 4,703,004, 4,782,137 and 4,851,341. Other patents pending. FLAG® and Anti-FLAG® are registered trademarks s of Sigma- Aldrich Co. M1, M2, and M5 are trademarks of Sigma-Aldrich Co. Use of this product is solely for investigational, experimental or research purposes. Not for commercial, diagnostic or therapeutic uses.

7. Use of labeling reagents may require licenses from entities other than Stratagene.

8. This product is covered by U.S. Patent Nos. 6,528,254 and 6,548,250. Purchase of this product conveys to the purchaser only the non-transferable right under these patents to use the product for research use only by the purchaser. No rights are granted to the purchaser hereunder to sell, modify for resale or otherwise transfer this product. Stratagene reserves all other rights, and this product may not be used in any manner other than as provided herein. Use of labeling reagents may require licenses from entities other than Stratagene.

9. Use of labeling reagents may require licenses from entities other than Stratagene. For example, use of fluorogenic probes in 5' nuclease assays may require licenses under U.S. Patent Nos. 6,214,979, 5,804,375, 5,210,015 and 5,487,972 owned by Roche Molecular Systems, Inc. and under U.S. Patent No. 5,538,848 owned by Applied Biosystems.

10. GeneEraser vectors are for research use only. Use in and/or for Diagnostic and Therapeutic, including but not limited to any use for drug screens and/or assays, is strictly prohibited.

11. Practice of the patented polymerase chain reaction (PCR) process requires a license. The RoboCycler® Thermal Cycler is an Authorized Thermal Cycler and may be used with PCR licenses available from Applied Biosystems. Its use with Authorized Reagents also provides a limited PCR license in accordance with the label rights accompanying such reagents.

12. GeneEraser™ siRNA Transfection Reagent is manufactured for Stratagene by Mirus

13. U.S. Patent No. 5,776,689, entitled "Protein Recruitment System" and covering this two-hybrid system, is owned by The Regents of the University of California and Baylor College of Medicine. Use of the two-hybrid system by commercial entities will require a license from The Regents of the University of California. For license information please contact: University of California, San Diego, Technology Transfer Office, Mailcode 0910, 9500 Gilman Drive, La Jolla, California 92093-0910; Telephone: (858) 534-5815; Facsimile: (858) 534-7345.

14. The bovine growth hormone (BGH) polyadenylation sequence is licensed under U. S. Patent No. 5,122,458 for research purposes only. "Research purposes" means uses directed to the identification of useful recombinant proteins and the investigation of the recombinant expression of proteins, which uses shall in no event include any of the following:

a. Any use in humans of a CLAIMED DNA or a CLAIMED CELL;

b. Any use in human of protein or other substance expressed or made at any stage of its production with the use of a CLAIMED DNA or a CLAIMED CELL;

c. Any use in which a CLAIMED DNA or CLAIMED CELL would be sold or transferred to another party other than Stratagene, its affiliate, or its sublicensee;

d. Any use in connection with the expression or production of a product intended for sale or commercial use; or

e. Any use for drug screening or drug development.

The term "CLAIMED DNA" means a DNA construct that contains the bgh polyadenylation signal and "CLAIMED CELL" means any eukaryotic cell or cell line that contains the bgh polyadenylation signal. Any use of the bgh polyadenylation signal that satisfies any one of parts (a) through (e) of the above definition requires a nonexclusive license from RCT. Inquires for licensing should be direct to Jennifer Tonzello Caldwell, Ph.D., Research Corporation Technologies, Tel: (520) 748-4400, Fax: (520) 748-0025.

15. Purchase of this PCR-related product does not convey any rights under the PCR patents owned by Roche Molecular Systems. A license to use the PCR process accompanies the purchase of certain reagents from Stratagene when used in conjunction with an Authorized Thermal Cycler.

16. Patents Pending.